ARMCX1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.497600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.600200E-01
Normal-vs-Stage2
1.604390E-01
Normal-vs-Stage3
1.474350E-01
Normal-vs-Stage4
3.080200E-01
Stage1-vs-Stage2
6.617700E-02
Stage1-vs-Stage3
2.458800E-01
Stage1-vs-Stage4
3.651600E-01
Stage2-vs-Stage3
8.546600E-01
Stage2-vs-Stage4
9.018800E-01
Stage3-vs-Stage4
7.985000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.635600E-01
Normal-vs-AfricanAmerican
4.080800E-01
Normal-vs-Asian
2.326600E-01
Caucasian-vs-AfricanAmerican
8.362600E-01
Caucasian-vs-Asian
4.880400E-01
AfricanAmerican-vs-Asian
5.172000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.284200E-01
Normal-vs-Female
3.980800E-01
Male-vs-Female
5.774400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.634200E-01
Normal-vs-Age(41-60Yrs)
5.931000E-01
Normal-vs-Age(61-80Yrs)
2.747800E-01
Normal-vs-Age(81-100Yrs)
7.096000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.461800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.952200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.678410E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.040830E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.296990E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.193400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.564000E-02
Normal-vs-Daily Drinker
6.393900E-02
Normal-vs-Weekly Drinker
3.125200E-01
Normal-vs-Occasional Drinker
8.146000E-01
Normal-vs-Social Drinker
8.036600E-01
Non Drinker-vs-Daily Drinker
7.793400E-01
Non Drinker-vs-Weekly Drinker
1.766440E-01
Non Drinker-vs-Occasional Drinker
9.488300E-02
Non Drinker-vs-Social Drinker
1.701150E-01
Daily Drinker-vs-Weekly Drinker
1.664220E-01
Daily Drinker-vs-Occasional Drinker
7.963600E-02
Daily Drinker-vs-Social Drinker
1.447400E-01
Weekly Drinker-vs-Occasional Drinker
4.421800E-01
Weekly Drinker-vs-Social Drinker
5.397600E-01
Occasional Drinker-vs-Social Drinker
9.542000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.620200E-01
Normal-vs-Grade 2
3.226600E-01
Normal-vs-Grade 3
4.589000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.501580E-01
Grade 1-vs-Grade 3
6.706000E-02
Grade 1-vs-Grade 4
3.620200E-01
Grade 2-vs-Grade 3
3.448800E-01
Grade 2-vs-Grade 4
3.226600E-01
Grade 3-vs-Grade 4
4.589000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.382600E-01
Normal-vs-NonDiabetic
3.537600E-01
Diabetic-vs-NonDiabetic
6.081600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.775820E-01
Normal-vs-NoPancreatitis
3.316600E-01
Pancreatitis-vs-NoPancreatitis
5.356400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.383800E-01
Normal-vs-N1
1.811350E-01
N0-vs-N1
4.139800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.732200E-02
Normal-vs-TP53-NonMutant
6.678000E-01
TP53-Mutant-vs-TP53-NonMutant
1.381570E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
